
1 - 10 employés
Fondée en 2017
🏥 Santé
🧬 Biotechnologie
💊 Pharmaceutique
💰 €100 000 000 Private Equity Round en 2022-04
Healthcare • Biotechnology • Pharmaceuticals
Dianthus Therapeutics, Inc. est une société de biotechnologie en phase clinique, spécialisée dans le développement de nouveaux anticorps monoclonaux pour traiter les maladies auto-immunes et inflammatoires sévères. L'entreprise utilise des technologies avancées d'ingénierie des anticorps pour créer des thérapies complémentaires de nouvelle génération avec une sélectivité et une puissance améliorées. Son programme principal, DNTH103, est un anticorps monoclonal ciblant la voie classique du complément pour des affections telles que la Myasthénie Grave généralisée, la Neuropathie Motrice Multifocale et la Polyneuropathie Démyélinisante Inflammatoire Chronique. Basée à New York et Waltham, Massachusetts, Dianthus vise à offrir des thérapies médicales transformatrices en répondant aux besoins non satisfaits dans le traitement des maladies auto-immunes.
🕒 il y a 1 mois
🗣️🇺🇸🇬🇧 Anglais requis
D'où vient cette offre
Publiée sur la page carrières de Dianthus Therapeutics, Inc., pas via un site d'emploi
Repérée par Remote Rocketship il y a 1 mois
Toujours ouverte sur le site de Dianthus Therapeutics, Inc.. Vérifiée il y a 9 heures.

1 - 10 employés
Fondée en 2017
🏥 Santé
🧬 Biotechnologie
💊 Pharmaceutique
💰 €100 000 000 Private Equity Round en 2022-04
Healthcare • Biotechnology • Pharmaceuticals
Dianthus Therapeutics, Inc. est une société de biotechnologie en phase clinique, spécialisée dans le développement de nouveaux anticorps monoclonaux pour traiter les maladies auto-immunes et inflammatoires sévères. L'entreprise utilise des technologies avancées d'ingénierie des anticorps pour créer des thérapies complémentaires de nouvelle génération avec une sélectivité et une puissance améliorées. Son programme principal, DNTH103, est un anticorps monoclonal ciblant la voie classique du complément pour des affections telles que la Myasthénie Grave généralisée, la Neuropathie Motrice Multifocale et la Polyneuropathie Démyélinisante Inflammatoire Chronique. Basée à New York et Waltham, Massachusetts, Dianthus vise à offrir des thérapies médicales transformatrices en répondant aux besoins non satisfaits dans le traitement des maladies auto-immunes.
• Define and execute the company-wide bioanalytical strategy, operating model, standards, and capability roadmap • Lead bioanalytical support across research, translational, and clinical programs, including PK, pharmacodynamic, immunogenicity, neutralizing antibody, biomarker, and program-specific assays • Provide scientific oversight for assay strategy, platform selection, critical reagents, method development, qualification and validation, technology transfer, sample analysis, data interpretation, and assay lifecycle management • Ensure assays and data are fit for purpose, scientifically rigorous, compliant with regulatory expectations, and available for key program decisions and milestones • Resolve complex assay, data, quality, and vendor issues with Quality, program teams, and external laboratories • Own or oversee bioanalytical content for regulatory submissions, briefing packages, health authority interactions, responses, and development reports • Represent Bioanalytical Sciences on program teams and governance forums, communicating scientific conclusions, risks, trade-offs, resource needs, and recommendations • Build, lead, and develop the Bioanalytical Sciences function through organizational design, recruitment, coaching, performance management, succession planning, and capability development • Develop and manage resourcing across employees, CROs, specialty laboratories, consultants, and technology partners • Lead external laboratory evaluation, selection, contracting input, onboarding, governance, performance management, issue escalation, and relationship management • Own functional budgets, headcount plans, consultant needs, capacity forecasts, and resource allocation • Establish processes, metrics, systems, and vendor oversight practices supporting quality, speed, accountability, and inspection readiness; evaluate technologies improving scientific and operational performance
• PhD or advanced equivalent degree in biochemistry, immunology, pharmacology, analytical chemistry, molecular biology, or a related scientific discipline • Typically, 15 or more years of progressive bioanalytical experience in biotechnology, pharmaceutical, or CRO environments • Significant functional and people leadership responsibility • Demonstrated success leading bioanalytical strategy across multiple programs and development stages, from nonclinical development through clinical studies and regulatory interactions • Deep expertise in bioanalytical method development, qualification, validation, transfer, troubleshooting, sample analysis, data review, and assay lifecycle management • Broad knowledge of PK, pharmacodynamic and biomarker assays, ligand-binding assays, anti-drug antibody and neutralizing antibody assays, cell-based or functional assays, flow cytometry, molecular methods, and LC-MS/MS • Strong knowledge of global bioanalytical regulatory expectations, GLP and GCP-regulated work, data integrity, inspection readiness, and regulatory submission support • Proven experience building and leading high-performing teams and managing delivery through CROs, specialty laboratories, consultants, and other external partners • Demonstrated ability to manage budgets, headcount and capacity plans, prioritize resources across a portfolio, and communicate complex scientific and operational matters clearly to executives and cross-functional teams • Sound scientific judgment, strong cross-functional influence, and ability to operate effectively in a growing, fast-paced biotechnology environment
• Remote work option • Opportunity to work on potentially best-in-class therapies for severe autoimmune diseases • Opportunity to build and lead the Bioanalytical Sciences function • Professional development through coaching, capability development, and succession planning responsibilities
Postuler MaintenantAméliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.
🕒 il y a 1 mois
Director managing retention, growth, and engagement for CuraLinc Healthcare’s EAP and wellness clients. Advising employer plan sponsors and representing a mental health care provider.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 1 mois
Director building KBKG’s national manufacturing sales channel for specialty tax solutions. Driving executive partnerships, qualified pipeline, and named-account growth.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 1 mois
Director overseeing BetterHealth’s healthcare IT infrastructure, cloud systems, integrations, security, and support operations. Leading technology strategy, compliance, vendors, and internal IT teams.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 1 mois
Director scaling strategic partnerships for CENTEGIX's emergency safety technology platform. Driving integrations, partner pipeline, and revenue across healthcare, education, government, and commercial sectors.
🇺🇸 États-Unis – Télétravail
💵 $150 000 / an
💰 Private Equity Round en 2021-08
⏰ Temps Plein
🔴 Expert
👔 Directeur
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 1 mois
Healthcare technology sales director growing public-sector and behavioral-health provider partnerships for CHESS Health. Owning complex sales cycles, territory strategy, pipeline, and $1.25 million annual target.
🇺🇸 États-Unis – Télétravail
💵 $100 000 - $125 000 / an
💰 €5 387 997 Venture Round - CHESS Health en 2021-12
⏰ Temps Plein
🔴 Expert
👔 Directeur
🗣️🇺🇸🇬🇧 Anglais requis